Economic, Financial Markets, Government, Politics, Russia

G20 warns that the global economic crisis is not yet over…

WORLD ECONOMY

At the end of the G20 last week, the leading group of nations said that the crisis in the global economy is far from over and more needs to be done to stimulate growth and create jobs around the world.

In a statement issued at the end of their summit in St Petersburg, Russia, G20 leaders welcomed a recovery in the developed world but warned of risks facing emerging markets.

The communique said:

… Despite our actions, the recovery is too weak, and risks remain tilted to the downside.

It listed ‘the main challenges’ facing the global economy, including ‘persistently high unemployment’ particularly among the young, financial stress in Europe and high levels of government debt.

The G20 also called for the withdrawal of emergency stimulus measures in countries such as the United States to be ‘carefully calibrated and clearly communicated’ to minimise volatility on the financial markets.

Speculation that the U.S. Federal Reserve is about to start reducing the level of support for the U.S. economy has plunged a number of emerging economies into turmoil.

The G20 is made up of developed countries and emerging markets accounting for 90 per cent of global output and two-thirds of the world’s population.

Standard
Foreign Affairs, Government, Middle East, Politics, Russia, Syria, United Nations, United States

G20 and America’s defining moment…

WATERSHED MOMENT

The G20 summit that ended in St Petersburg yesterday failed to produce any kind of agreement on the Syrian crisis. The chasm and bridge separating the United States and Russia on Syria is as wide as it has ever been. Yet, few such gatherings in recent years have offered a truer picture of how and where the real balance of global power lies. A genuine watershed in international affairs may at last have arrived; replacing a vestige of what has been referred to of late as the ‘Arab Spring’ – a term synonymous with upheaval and chaos spreading through many Islamic states.

Related:

The two-day gathering in St Petersburg have confirmed many things. It underscored, for example, just how determined Vladimir Putin is in reasserting Russia on the world stage. It displayed quite clearly, too, that a mercantilist China will do nothing to unsettle its economic interests, and in the process laid bare Europe’s total inability to act on its own.

A senior Kremlin official was reported to have said that no one pays any attention to Britain, a ‘small island’. But could the same not be said of the rest of the EU? Germany, for instance, Europe’s economic powerhouse, is notable only for its deafening silence. France, eager to push a military agenda in punishing the Assad regime for its alleged use of chemical weapons, is unwilling to do so without America’s lead. Other G20 participants wring their hands in aghast and disbelief at what is happening in Syria, but most are keen to shriek away from any involvement. At a moment of high international drama, it leads us back – as it invariably does – to the United States and its role in the world.

It shouldn’t have required a Kremlin official to point out Britain’s diminished influence in the world; the empire ended more than half-a-century ago. But, like it or not, with the United Nations no more than a fractious and divided talking shop, the U.S. is the closest thing we have to a global policeman. No country, it has been argued, has the right to behave as such, and America’s actual ability to change history, for all its military might and superpower status, is sometimes exaggerated – not least by itself. We need to look no further than the sorry state of Iraq, a decade after George W Bush’s invasion, to provide clarity to the argument. In any major crisis, however, all eyes turn to Washington, as they are now in Syria as the regime is accused of violating a ban on the use of chemical weapons. Syria is a signatory against the banned use of such weapons, and yet here we have a paralysed UN Security Council that is powerless to enforce an international binding treaty.

With a vote in Congress on the use of U.S. military force in Syria to be held on the 9th September, the next few days will be decisive. Britain’s role on the world stage has been diminished given the veto in the House of Commons last week, but for President Obama the stakes are vastly higher. On Syria, Mr Obama’s approach has been feckless. First, he declared that Assad must go without saying how, and then laid down his ‘red lines’ over the use of chemical weapons. Later, he announced his decision to use force, and more recently has passed the buck to Congress on Capitol Hill. Deep down, many will suspect that he would prefer to stay well out of Syria given what has happened in Iraq, Afghanistan and Libya. Syria is ablaze and arguably much more contentious than anything the United States has dealt with in the past 30-years. Mr Obama’s uncertainty in how to proceed in Syria is resonating in all corners of the world.

If present indications are anything to go on, the House of Representatives could well follow the House of Commons in opposing military action. If so, a definitive moment will have arrived. Unlike David Cameron, Obama will either defy his legislature and go ahead with strikes, or he will acquiesce, and there will be no military response. If military action is taken off the table, not only would Barack Obama’s presidency be gravely weakened at home, but in the eyes of the world so too would the credibility of America as a global policeman. Either way, a watershed is at hand.

Standard
Britain, Health, Medical, Research, Science

A simple surgical operation to cure high blood pressure…

CLINICAL TRIALS START FOR TREATING HYPERTENSION

British scientists believe they could cure millions of patients with hard-to-treat high blood pressure and hypertension.

A simple operation would involve removing a small cluster of nerves in the throat linked to blood pressure regulation.

Researchers from Bristol University are extremely hopeful the measures could help some 2.5 million individuals with hypertension that cannot be controlled by medication.

While scientists have already started a clinical trial on 20 people with high blood pressure – following successful laboratory tests on rats – if the trials prove to be successful and is given the go-ahead, the surgical procedure could be available within three years as a ‘relatively simple’ day treatment for adults. The novel approach successfully ‘cured’ the condition in laboratory rats.

The carotid body is one of the body’s smallest organs but acts as a sensor that detects changes in gas levels in the blood. Sometimes, however, it can become overactive.

The carotid body is one of the body’s smallest organs but acts as a sensor that detects changes in gas levels in the blood. Sometimes, however, it can become overactive.

Known as the silent killer, high blood pressure or hypertension affects a third of adults and significantly raises the odds of heart attacks, strokes and other potentially fatal conditions if left untreated.

At the moment, there is no effective remedy for individuals who do not respond to conventional drug therapies.

But scientists at Bristol’s School of Physiology and Pharmacology identified a key organ in the development of high blood pressure – the carotid body.

It consists of a tiny cluster of nerve cells that sit on the side of the two branches of the carotid artery in the neck, each the size of a grain of rice.

Despite being one of the body’s smallest organs, it has the highest blood flow of them all – reflecting its importance as an early warning device for the brain if there is any change to oxygen and carbon dioxide levels in the blood.

In some cases, it is thought the carotid body becomes overactive and sends a message to the brain to keep blood pressure high. Scientists involved in removing the organs in rats with hypertension found that blood pressure fell and remained low.

The study, which was funded by the British Heart Foundation, and first published in the journal Nature Communications, said the animals suffered no adverse side-effects either.

In human trials, only one carotid body would be removed in order to reduce blood pressure while maintaining the organ’s vital regulatory function.

Professor Julian Paton who is the lead researcher on the study, said:

… We know that these tiny organs behaved differently in conditions of hypertension, but had absolutely no idea that they contributed so massively to the generation of high blood pressure; this is really most exciting.

… It certainly has the potential to be a very novel interventional approach to drug-resistant hypertension (high blood pressure).

An estimated 16 million British adults have high blood pressure; a third of whom may be unaware they have the condition.

Patients are often at first advised to alter their lifestyle by taking more exercise, stopping smoking, cutting down on drinking and limiting the salt and fat in their diet.

GPs can also prescribe medication – often a combination of pills – but many patients skip doses because of the side-effects caused by most treatments. Up to 15 per cent of patients – 2.5 million people – also struggle to control their condition using drugs.

Professor Jeremy Pearson, associate medical director at the British Heart Foundation, said:

… This potential new treatment has real promise to help this hard-to-treat group of patients … Many patients can control their blood pressure adequately by lifestyle change and medication so they would not be offered this kind of treatment.

… It is therefore unlikely this treatment will ever be tested as an alternative to standard medication – only as an extra procedure when current drug treatment fails.

A consultant cardiologist at Sheffield Teaching Hospital referred to the breakthrough as an ‘exciting and innovative approach’ and added that current treatments for high blood pressure have serious drawbacks, such as no-one likes taking multiple tablets and that medics are often guilty of not explaining properly why treatment is needed and what benefits might be expected.

Standard